Compounds > oxaunomycin
Page last updated: 2024-09-04

oxaunomycin and Leukemia L 1210

oxaunomycin has been researched along with Leukemia L 1210 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Johdo, O; Nishida, H; Okamoto, R; Takeuchi, T; Yoshimoto, A1
Demant, EJ; Friche, E; Hansen, HH; Jensen, PB; Kjeldsen, E; Sehested, M; Sørensen, BS1
Fujii, S; Ishikura, T; Johdo, O; Kubo, K; Naganawa, H; Sawa, T; Takeuchi, T; Umezawa, H; Yoshimoto, A1

Other Studies

3 other study(ies) available for oxaunomycin and Leukemia L 1210

ArticleYear
New anthracycline antibiotics 10-epi-oxaunomycin and 10-epi-11-deoxyoxaunomycin.
    The Journal of antibiotics, 1995, Volume: 48, Issue:10

    Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Chromatography, High Pressure Liquid; Leukemia L1210; Molecular Conformation; Structure-Activity Relationship

1995
Different modes of anthracycline interaction with topoisomerase II. Separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistance.
    Biochemical pharmacology, 1993, May-25, Volume: 45, Issue:10

    Topics: Aclarubicin; Animals; Anthracyclines; Antibiotics, Antineoplastic; Carcinoma, Small Cell; DNA Damage; DNA Topoisomerases, Type II; DNA, Neoplasm; Drug Interactions; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Leukemia L1210; Lung Neoplasms; Mice; Naphthacenes; Stimulation, Chemical; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tumor Cells, Cultured

1993
Intensely potent anthracycline antibiotic oxaunomycin produced by a blocked mutant of the daunorubicin-producing microorganism.
    The Journal of antibiotics, 1986, Volume: 39, Issue:7

    Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry; Daunorubicin; Leukemia L1210; Mice; Mutation; Naphthacenes; Streptomyces

1986